To the full analysis
DaVita stock: growth
DVADaVita reported $13.64B in revenue for fiscal 2025, up 6.5% on the prior year, up 3.4% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
5.6%
per year from 2006 to 2025, per share 11.4%
Earnings (Annual rate)
5.1%
per year from 2006 to 2025, per share 10.9%
Free cash flow (Annual rate)
9.1%
per year from 2006 to 2025, per share 15.1%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 3.4% | −0.1% | 5.6% |
| Revenue per share | 13.8% | 10.9% | 11.4% |
| Earnings | −0.7% | 10.7% | 5.1% |
| Earnings per share | 9.0% | 23.0% | 10.9% |
| Free cash flow | 0.1% | 4.4% | 9.1% |
| Free cash flow per share | 10.2% | 16.0% | 15.1% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $4.88B | $289.69M | $251.27M |
| 2007 | $5.26B | $381.78M | $258.53M |
| 2008 | $5.66B | $374.16M | $237.9M |
| 2009 | $6.11B | $422.68M | $391.78M |
| 2010 | $6.45B | $405.68M | $566.08M |
| 2011 | $6.79B | $478M | $779.89M |
| 2012 | $8.19B | $536.02M | $550.7M |
| 2013 | $11.76B | $633.45M | $1.15B |
| 2014 | $12.8B | $723.11M | $817.06M |
| 2015 | $13.78B | $269.73M | $849.2M |
| 2016 | $14.75B | $879.87M | $1.13B |
| 2017 | $10.88B | $663.62M | $1B |
| 2018 | $11.4B | $159.39M | $784.5M |
| 2019 | $11.39B | $810.98M | $1.31B |
| 2020 | $11.55B | $773.64M | $1.3B |
| 2021 | $11.62B | $978.45M | $1.29B |
| 2022 | $11.61B | $560.4M | $961.14M |
| 2023 | $12.14B | $691.54M | $1.49B |
| 2024 | $12.82B | $936.34M | $1.47B |
| 2025 | $13.64B | $746.8M | $1.31B |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 4 Nov 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.